Aim2Cerv
    USA flag

Cancer immunotherapy consists of a variety of treatments that boost or restore the ability of your body’s immune system to recognize and fight cancer. Some immunotherapy treatments can work in a general way to boost the overall immune system while others can work in a very targeted way.

ADXS11-001 is a targeted immunotherapy approach that is designed to stimulate the immune system to identify and attack human papilloma virus (HPV) associated tumor cells.

ADXS11-001 is an investigational product which has not been approved by the Food & Drug Administration (FDA).